Tag Archives: NSPR

Top Biotech Stocks To Own For 2019

Stocks powered higher on news of a trade agreement between the U.S. and Mexico. The Dow Jones Industrial Average (DJINDICES:^DJI) broke 26,000 for the first time since February, and the S&P 500 (SNPINDEX:^GSPC) closed at a record high.

Today’s stock market

Index Percentage Change Point Change

Dow 1.01% 259.29
S&P 500 0.77% 22.05

Data source: Yahoo! Finance.

Biotech stocks surged, with the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB) rising 1.8%. The retail sector was weak; the SPDR S&P Retail ETF (NYSEMKT:XRT) slipped 0.7%. 

As for individual stocks, Tesla (NASDAQ:TSLA) investors largely shrugged off the announcement that it will remain a public company, and Pfizer (NYSE:PFE) presented details of a drug trial that had big implications for smaller competitors.

Image source: Getty Images.

Top Biotech Stocks To Own For 2019: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top Biotech Stocks To Own For 2019: Beasley Broadcast Group Inc.(BBGI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Beasley Broadcast Group (NASDAQ:BBGI) Director Mark S. Fowler sold 5,505 shares of the company’s stock in a transaction dated Friday, May 18th. The stock was sold at an average price of $10.78, for a total value of $59,343.90. Following the sale, the director now owns 34,199 shares of the company’s stock, valued at $368,665.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Top Biotech Stocks To Own For 2019: Huntington Ingalls Industries, Inc.(HII)

Advisors’ Opinion:

  • [By Lou Whiteman]

    Huntington Ingalls Industries (NYSE:HII) and Lockheed Martin (NYSE:LMT)are each up about 25% over the past year, though Lockheed is significantly higher valued on both a price-to-earnings and price-to-sales basis. Let’s take a look at the prospects for both companies with an eye toward determining which is a better buy right now.

  • [By Lou Whiteman]

    More specifically, the budgeting process resulted in big wins relative to what the Pentagon requested for Lockheed Martin (NYSE:LMT), good news for Huntington Ingalls (NYSE:HII), and reason to hope that Textron (NYSE:TXT) can expand its military business.

  • [By Lou Whiteman]

    The bull case for shipbuilder Huntington Ingalls (NYSE:HII) is centered in no small part on the company’s place as the sole builder and maintainer of the nation’s fleet of nuclear-powered aircraft carriers. A reported shift in Navy thinking over the need for a massive carrier fleet could challenge Huntington’s growth expectations, though it’s too soon for investors to react to the speculation.

  • [By Rich Smith]

    Military shipbuilder Huntington Ingalls (NYSE:HII) beat its earnings estimates for the fourth quarter of 2018. In the report delivered earlier this month, it revealed that sales increased  10% year over year for both the quarter and the year as a whole. Profits more than tripled for the quarter, and were up a lower, but still staggering, 82.5% for the year — to $19.09 per diluted share.

  • [By Paul Ausick]

    The carriers are being constructed by Huntington Ingalls Industries Inc. (NYSE: HII) at a total acquisition cost of around $55 billion. Work on the carriers provides more than 20,000 jobs at Huntington’s Newport News shipyard.

  • [By Money Morning News Team]

    Huntington Ingalls Industries Inc. (NYSE: HII) is a major U.S. shipbuilding company that is involved in the design, construction, maintenance, and repair of both nuclear and non-nuclear vessels on behalf of the U.S. Navy and Coast Guard. It also refuels, overhauls, and deactivates nuclear-powered ships.

Top 10 Warren Buffett Stocks To Buy Right Now

Warren Buffett and Jamie Dimon want companies to stop giving quarterly earnings forecasts and focus on the long term. Even investors seeking short-term gains might want to heed their point of view.

You’d think that providing a forecast every three months would make a company’s results more predictable. But since 2016, S&P 500 Index members that provide quarterly outlooks ended up reporting more surprises — or a wider gap between earnings and estimates — than the index as a whole. The group of companies that gave guidance only got closer to the consensus in two of the nine calendar quarters.

Bad Advice

Quarterly guidance has resulted in bigger earnings surprises since 2016

Source: Bloomberg

.chart-js { display: none; }

“Quarterly results are a piece of the investment mosaic, but we find little value in quarterly guidance for active managers performing their own research,” said Christopher Hillary, chief executive officer and portfolio manager at Denver-based Roubaix Capital, the $112 million hedge fund firm that focuses on small-cap stocks. “Long-term goals are a more useful tool in evaluating a business, as well as a means of holding the management and board accountable.”

Top 10 Warren Buffett Stocks To Buy Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Todd Campbell]

    In this clip of The Motley Fool’s Industry Focus Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to discuss LOXO-292’s opportunity and how competitor Blueprint Medicines (NASDAQ:BPMC) is challenging it. Also, the two analysts discuss why shares in Abiomed, Inc. (NASDAQ:ABMD) are soaring higher and if this is a high-priced stock that investors should embrace or ignore.

Top 10 Warren Buffett Stocks To Buy Right Now: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    National General (NASDAQ: NGHC) and AmTrust Financial Services (NASDAQ:AFSI) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top 10 Warren Buffett Stocks To Buy Right Now: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By John Bromels]

    Three companies that the market has walloped areApache Corporation(NYSE:APA),Magellan Midstream Partners(NYSE:MMP), andGeneral Motors(NYSE:GM). Here’s why these stocks look like bargains, and why today might be a good time to scoop up some shares.

  • [By Reuben Gregg Brewer]

    For an example of just how important this is, take a look at the graph below. Midstream companies ONEOK Inc. (NYSE:OKE), Magellan Midstream Partners LP(NYSE:MMP), and Enterprise Products Partners L.P. (NYSE:EPD) have each increased their disbursements for more than a decade. However, there is a difference in the growth rates over time. Enterprise’s 10-year annualized distribution increase was 5.7%, Magellan’s was 10.9%, and ONEOK’s dividend rose at an annualized 16.1% clip. Just a few percentage points here makes a huge difference in the growth of the disbursement over time, as the chart below clearly shows.

  • [By Reuben Gregg Brewer]

    The midstream partnership sector is deeply out of favor today, despite the fact that these companies provide vital services moving and processing oil and natural gas. For conservative investors, Enterprise Products Partners L.P. (NYSE:EPD) and Magellan Midstream Partners, L.P. (NYSE:MMP) are two high-yield stocks that appear to be on sale today, still off roughly 30% and 20% from their 2014 highs, respectively. Here’s what you need to know to decide if Enterprise or Magellan is the better buy for you.

Top 10 Warren Buffett Stocks To Buy Right Now: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Haynes International (NASDAQ:HAYN) from a hold rating to a sell rating in a report released on Saturday morning.

    Several other brokerages have also recently issued reports on HAYN. Zacks Investment Research cut Haynes International from a buy rating to a hold rating and set a $50.00 target price on the stock. in a report on Tuesday, March 13th. ValuEngine raised Haynes International from a hold rating to a buy rating in a report on Thursday, April 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. Haynes International currently has an average rating of Hold and a consensus target price of $35.00.

Top 10 Warren Buffett Stocks To Buy Right Now: STAAR Surgical Company(STAA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) hit a new 52-week high and low during mid-day trading on Friday . The company traded as low as $28.55 and last traded at $28.42, with a volume of 6590 shares changing hands. The stock had previously closed at $27.80.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 28 percent to $21.40 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 57 percent to $34.52. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 26 percent to $21.03 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 56 percent to $34.2425. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

Top 10 Warren Buffett Stocks To Buy Right Now: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

  • [By Ethan Ryder]

    Tech Data (NASDAQ: TECD) and ePlus (NASDAQ:PLUS) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

  • [By Stephan Byrd]

    Teacher Retirement System of Texas decreased its position in ePlus (NASDAQ:PLUS) by 36.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 3,093 shares of the software maker’s stock after selling 1,754 shares during the period. Teacher Retirement System of Texas’ holdings in ePlus were worth $240,000 as of its most recent filing with the SEC.

  • [By ]

    “When and where will all of the many conflicts of interest be listed by the 13 Angry Democrats (plus) working on the Witch Hunt Hoax,” Trump said of the probe on Twitter Thursday. “There has never been a group of people on a case so biased or conflicted. It is all a Democrat Excuse for LOSING the Election.”

  • [By Max Byerly]

    Uniplan Investment Counsel Inc. reduced its stake in ePlus (NASDAQ:PLUS) by 1.1% during the 1st quarter, HoldingsChannel reports. The fund owned 116,594 shares of the software maker’s stock after selling 1,335 shares during the period. Uniplan Investment Counsel Inc.’s holdings in ePlus were worth $9,059,000 at the end of the most recent reporting period.

Top 10 Warren Buffett Stocks To Buy Right Now: Nuveen Tax-Advantaged Total Return Strategy Fund(JTA)

Advisors’ Opinion:

  • [By Max Byerly]

    Wells Fargo & Company MN decreased its holdings in Nuveen Tax Advantaged Total Re (NYSE:JTA) by 48.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,813 shares of the investment management company’s stock after selling 10,055 shares during the period. Wells Fargo & Company MN owned approximately 0.08% of Nuveen Tax Advantaged Total Re worth $150,000 as of its most recent SEC filing.

Top 10 Warren Buffett Stocks To Buy Right Now: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Warren Buffett Stocks To Buy Right Now: Industrias Bachoco, S.A. de C.V.(IBA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Industrias Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Bachoco (NYSE:IBA) declared a semiannual dividend on Thursday, April 26th, NASDAQ reports. Stockholders of record on Friday, May 11th will be given a dividend of 0.432 per share on Monday, May 21st. This represents a dividend yield of 1.53%. The ex-dividend date is Thursday, May 10th. This is a boost from Bachoco’s previous semiannual dividend of $0.42.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Industrias Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Buy Right Now: Can-Fite Biopharma Ltd(CANF)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Co-Diagnostics, Inc. (NASDAQ: CODX) jumped 88 percent to $5.4500 after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) climbed 40.3 percent to $5.40 after the company declared a $0.70 per share special dividend.
    Future FinTech Group Inc. (NASDAQ: FTFT) rose 27 percent to $2.73. Future FinTech disclosed a strategic transformation plan including expanding on current blockchain business while also becoming a blockchain incubator, investment and asset management, training, and management consulting.
    SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 14.7 percent to $5.9522 after the company disclosed that its Phase 2b trial of NeuVax in combo with Trastuzumab in HER1+/2+ breast cancer patients met key clinical objectives.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares climbed 14.6 percent to $120.4224 after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    FTE Networks, Inc. (NASDAQ: FTNW) gained 10.5 percent to $20.9399.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 9 percent to $8.07. Leerink Swann upgraded T2 Biosystems from Market Perform to Outperform.
    Zuora, Inc. (NYSE: ZUO) shares rose 8.3 percent to $24.01 after the company reported upbeat Q1 earnings and issued strong outlook.
    VMware, Inc. (NYSE: VMW) rose 7.7 percent to $148.07 as the company reported stronger-than-expected results for its first quarter on Thursday.
    Ambac Financial Group, Inc. (NASDAQ: AMBC) gained 7.5 percent to $19.91. Ambac Financial will replace Integra Lifesciences Holdings in the S&P SmallCap 600 on Tuesday, June 5.
    Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) gained 7 percent to $4.60.
    Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 6.6 percent to $18.23.
    Franklin Street Properties Corp. (NYSE: FSP) gained 5.7 perce
  • [By Max Byerly]

    CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Shane Hupp]

    Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Best Oil Stocks To Buy Right Now

There’s a major discrepancy over the value of Saudi Arabia’s state-owned oil company, and that could have a big effect on theSaudi Aramco IPO price.

Since Saudi Aramco first announced it was preparing for an IPO in January 2016, the company and other analysts have valued it at over $2 trillion dollars. Even if the Saudi Aramco IPO only offers 5% of the company to the public, the $100 billion value would still be the biggest IPO of all time.

But this week (April 25), officials are questioning the accuracy of the massive Saudi Aramco valuation. In fact, Saudi officials now say the $2 trillion Aramco IPO valuation could be off by more than $500 billion. That’s even after Saudi Arabia slashed the tax rate for Aramco from 85% to 50% to make it more attractive for investors.

Best Oil Stocks To Buy Right Now: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    InspireMD Inc (NYSE: NSPR) was down, falling around 35 percent to $1.29. InspireMD reported the pricing of public offering of up to $7.5 million.

    Commodities

Best Oil Stocks To Buy Right Now: Pacific Gas & Electric Co.(PCG)

Advisors’ Opinion:

  • [By David Dittman]

    PG&E Corp (NYSE: PCG), Edison International (NYSE: EIX) and Sempra Energy (NYSE: SRE) are the parent entities of California’s investor-owned utilities.

Best Oil Stocks To Buy Right Now: Noah Holdings Ltd.(NOAH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Noah Holdings Limited (ADR) (NYSE: NOAH) is estimated to post financial results for its latest quarter.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets